Effectiveness of Bone Metastases Treatment by Sm-153 Oxabifore in Combination with Monoclonal Antibody Denosumab (Xgeva): First Experience

por Rasulova, Nigora, Lyubshin, Vladimir, Arybzhanov, Dauranbek, Krylov, Valery, Khodjibekov, Marat
Publicado 2013

Optimal Timing of Bisphosphonate Administration in Combination with Samarium-153 Oxabifore in the Treatment of Painful Metastatic Bone Disease

por Rasulova, Nigora, Lyubshin, Vladimir, Arybzhanov, Dauranbek, Sagdullaev, Sh., Krylov, Valery, Khodjibekov, Marat
Publicado 2013

Molecular genetic tests in survival factors in patients with NSCLC in the clinical practice of Kazakhstan

por Yessentayeva, Suriya Ye., Makarov, Valeriy A., Kalmatayeva, Zhanna A., Zhakenova, Zhanar K., Arybzhanov, Dauranbek T.
Publicado 2021